SI1912649T1 - Derivati kinolina kot antibakterijska sredstva - Google Patents

Derivati kinolina kot antibakterijska sredstva

Info

Publication number
SI1912649T1
SI1912649T1 SI200631469T SI200631469T SI1912649T1 SI 1912649 T1 SI1912649 T1 SI 1912649T1 SI 200631469 T SI200631469 T SI 200631469T SI 200631469 T SI200631469 T SI 200631469T SI 1912649 T1 SI1912649 T1 SI 1912649T1
Authority
SI
Slovenia
Prior art keywords
antibacterial agents
quinoline derivatives
quinoline
derivatives
antibacterial
Prior art date
Application number
SI200631469T
Other languages
English (en)
Slovenian (sl)
Inventor
Koenraad Jozef Lodewijk Marcel Andries
Anil Koul
Jerome Emile Georges Guillemont
Elisabeth Therese Jeanne Pasquier
Original Assignee
Janssen Pharmaceutica, N.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35768115&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SI1912649(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Janssen Pharmaceutica, N.V. filed Critical Janssen Pharmaceutica, N.V.
Publication of SI1912649T1 publication Critical patent/SI1912649T1/sl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/10Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/4709Non-condensed quinolines and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/53751,4-Oxazines, e.g. morpholine
    • A61K31/53771,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
SI200631469T 2005-08-03 2006-07-31 Derivati kinolina kot antibakterijska sredstva SI1912649T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP05107155 2005-08-03
PCT/EP2006/064847 WO2007014934A2 (en) 2005-08-03 2006-07-31 Quinoline derivatives as antibacterial agents
EP06792614A EP1912649B1 (en) 2005-08-03 2006-07-31 Quinoline derivatives as antibacterial agents

Publications (1)

Publication Number Publication Date
SI1912649T1 true SI1912649T1 (sl) 2013-01-31

Family

ID=35768115

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200631469T SI1912649T1 (sl) 2005-08-03 2006-07-31 Derivati kinolina kot antibakterijska sredstva

Country Status (30)

Country Link
US (1) US8691800B2 (enExample)
EP (1) EP1912649B1 (enExample)
JP (1) JP5208739B2 (enExample)
KR (1) KR101413094B1 (enExample)
CN (1) CN101277698B (enExample)
AP (1) AP2483A (enExample)
AR (1) AR054888A1 (enExample)
AU (1) AU2006274873B2 (enExample)
BR (1) BRPI0614099B8 (enExample)
CA (1) CA2615900C (enExample)
CY (1) CY1113535T1 (enExample)
DK (1) DK1912649T3 (enExample)
EA (1) EA014834B1 (enExample)
ES (1) ES2397358T3 (enExample)
HR (1) HRP20120910T1 (enExample)
IL (1) IL189140A (enExample)
JO (1) JO2837B1 (enExample)
ME (1) ME01485B (enExample)
MX (1) MX2008001601A (enExample)
MY (1) MY147637A (enExample)
NO (1) NO342328B1 (enExample)
NZ (1) NZ566012A (enExample)
PL (1) PL1912649T3 (enExample)
PT (1) PT1912649E (enExample)
RS (1) RS52606B (enExample)
SI (1) SI1912649T1 (enExample)
TW (1) TWI385168B (enExample)
UA (1) UA95911C2 (enExample)
WO (1) WO2007014934A2 (enExample)
ZA (1) ZA200801106B (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JO2837B1 (en) 2005-08-03 2014-09-15 جانسن فارمسيتكا ان في Quinoline derivatives acting as antibacterial agents
JO3271B1 (ar) * 2006-12-06 2018-09-16 Janssen Pharmaceutica Nv مشتقات الكوينولين المضادة للجراثيم
JO2683B1 (en) * 2006-12-06 2013-03-03 جانسين فارماسوتيكا ان. في Quinoline antibacterial derivatives
JP5246715B2 (ja) * 2009-01-27 2013-07-24 独立行政法人科学技術振興機構 蛋白質架橋阻害剤およびその用途
CN104254528B (zh) 2012-04-27 2017-06-06 詹森药业有限公司 抗菌的喹啉衍生物
US9133167B2 (en) 2012-04-27 2015-09-15 Janssen Pharmaceutica Nv Antibacterial quinoline derivatives
EA201891644A1 (ru) * 2016-03-07 2019-04-30 Зе Глобал Эллайенс Фо Тб Драг Девелопмент, Инк. Антибактериальные соединения и их применение

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001503411A (ja) * 1996-10-28 2001-03-13 ディパートメント オブ ジ アーミー,ユー.エス.ガバメント 抗生物質耐性感染症の処置のための化合物、組成物および方法
US6103905A (en) * 1997-06-19 2000-08-15 Sepracor, Inc. Quinoline-indole antimicrobial agents, uses and compositions related thereto
GB0101577D0 (en) * 2001-01-22 2001-03-07 Smithkline Beecham Plc Compounds
AR040336A1 (es) * 2002-06-26 2005-03-30 Glaxo Group Ltd Compuesto de piperidina, uso del mismo para la fabricacion de un medicamento, composicion farmaceutica que lo comprende y procedimiento para preparar dicho compuesto
RS52431B (sr) * 2002-07-25 2013-02-28 Janssen Pharmaceutica N.V. Derivati hinolina i njihova upotreba kao mikobakterijskih inhibitora
EP1711492B1 (en) * 2004-01-23 2008-04-16 Janssen Pharmaceutica N.V. Substituted quinolines and their use as mycobacterial inhibitors
JO2837B1 (en) 2005-08-03 2014-09-15 جانسن فارمسيتكا ان في Quinoline derivatives acting as antibacterial agents

Also Published As

Publication number Publication date
JP5208739B2 (ja) 2013-06-12
RS52606B (sr) 2013-04-30
BRPI0614099B8 (pt) 2021-05-25
ZA200801106B (en) 2009-09-30
HRP20120910T1 (hr) 2012-12-31
UA95911C2 (ru) 2011-09-26
NZ566012A (en) 2011-02-25
KR20080039961A (ko) 2008-05-07
KR101413094B1 (ko) 2014-07-01
JP2009503021A (ja) 2009-01-29
AU2006274873B2 (en) 2012-12-13
JO2837B1 (en) 2014-09-15
TW200800971A (en) 2008-01-01
TWI385168B (zh) 2013-02-11
NO342328B1 (no) 2018-05-07
IL189140A (en) 2014-07-31
WO2007014934A2 (en) 2007-02-08
AP2483A (en) 2012-10-01
MY147637A (en) 2012-12-31
AU2006274873A1 (en) 2007-02-08
US20080227775A1 (en) 2008-09-18
CY1113535T1 (el) 2016-06-22
IL189140A0 (en) 2008-08-07
ES2397358T3 (es) 2013-03-06
EA200800513A1 (ru) 2008-06-30
CN101277698A (zh) 2008-10-01
EP1912649A2 (en) 2008-04-23
CA2615900A1 (en) 2007-02-08
BRPI0614099A2 (pt) 2011-03-09
BRPI0614099B1 (pt) 2019-11-12
EP1912649B1 (en) 2012-10-10
NO20081068L (no) 2008-02-29
WO2007014934A8 (en) 2007-05-18
DK1912649T3 (da) 2013-01-21
PL1912649T3 (pl) 2013-03-29
CN101277698B (zh) 2011-06-22
AR054888A1 (es) 2007-07-25
PT1912649E (pt) 2013-01-14
CA2615900C (en) 2014-12-09
WO2007014934A3 (en) 2007-04-05
ME01485B (me) 2014-04-20
MX2008001601A (es) 2008-02-19
HK1124232A1 (zh) 2009-07-10
EA014834B1 (ru) 2011-02-28
US8691800B2 (en) 2014-04-08

Similar Documents

Publication Publication Date Title
ZA200801108B (en) Quinoline derivatives as antibacterial agents
IL187904A0 (en) Quinoline derivatives as antibacterial agents
ZA200801110B (en) Quinoline derivatives as antibacterial agents
IL184844A0 (en) ??-cyclodextrin derivatives as antibacterial agents
ZA200800783B (en) Antibacterial quinoline derivatives
IL188395A0 (en) Quinoline derivatives as antibacterial agents
ZA200801106B (en) Quinoline derivatives as antibacterial agents
IL188393A0 (en) Quinoline derivatives as antibacterial agents
IL188394A0 (en) Quinoline derivatives as antibacterial agents
ZA200710698B (en) Quinoline derivatives as antibacterial agents